title: Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
abstract: During transrectal ultrasound (TRUS)-guided prostate biopsies, the actual location of the biopsy site is rarely documented. Here, we demonstrate the capability of TRUS-magnetic resonance imaging (MRI) image fusion to document the biopsy site and correlate biopsy results with multi-parametric MRI findings. Fifty consecutive patients (median age 61 years) with a median prostate-specific antigen (PSA) level of 5.8 ng/ml underwent 12-core TRUS-guided biopsy of the prostate. Pre-procedural T2-weighted magnetic resonance images were fused to TRUS. A disposable needle guide with miniature tracking sensors was attached to the TRUS probe to enable fusion with MRI. Real-time TRUS images during biopsy and the corresponding tracking information were recorded. Each biopsy site was superimposed onto the MRI. Each biopsy site was classified as positive or negative for cancer based on the results of each MRI sequence. Sensitivity, specificity, and receiver operating curve (ROC) area under the curve (AUC) values were calculated for multi-parametric MRI. Gleason scores for each multi-parametric MRI pattern were also evaluated. Six hundred and 5 systemic biopsy cores were analyzed in 50 patients, of whom 20 patients had 56 positive cores. MRI identified 34 of 56 positive cores. Overall, sensitivity, specificity, and ROC area values for multi-parametric MRI were 0.607, 0.727, 0.667, respectively. TRUS-MRI fusion after biopsy can be used to document the location of each biopsy site, which can then be correlated with MRI findings. Based on correlation with tracked biopsies, T2-weighted MRI and apparent diffusion coefficient maps derived from diffusion-weighted MRI are the most sensitive sequences, whereas the addition of delayed contrast enhancement MRI and three-dimensional magnetic resonance spectroscopy demonstrated higher specificity consistent with results obtained using radical prostatectomy specimens.
authors: National Cancer Institute, NIH, Bethesda, MD, USA.
authors: Baris
authors: B
authors: Turkbey
authors: Sheng
authors: S
authors: Xu
authors: Jochen
authors: J
authors: Kruecker
authors: Julia
authors: J
authors: Locklin
authors: Yuxi
authors: Y
authors: Pang
authors: Vijay
authors: V
authors: Shah
authors: Marcelino
authors: M
authors: Bernardo
authors: Angelo
authors: A
authors: Baccala
authors: Ardeshir
authors: A
authors: Rastinehad
authors: Compton
authors: C
authors: Benjamin
authors: Maria J
authors: MJ
authors: Merino
authors: Bradford J
authors: BJ
authors: Wood
authors: Peter L
authors: PL
authors: Choyke
authors: Peter A
authors: PA
authors: Pinto
mesh_terms: D000368:Aged; D001706:Biopsy / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D012372:ROC Curve; D012680:Sensitivity and Specificity; D012984:Software; D014463:Ultrasonography / Q000379:methods